NeuroSigma taps CCG for IR

LOS ANGELES: NeuroSigma, a medical technology company, has appointed CCG Investor Relations to implement a strategic communications and investor relations campaign.

LOS ANGELES: NeuroSigma, a medical technology company, has appointed CCG Investor Relations to implement a strategic communications and investor relations campaign.

NeuroSigma develops therapies in clinical trials that target epilepsy, depression, post-traumatic stress disorders, and obesity.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.